These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7641166)

  • 1. Requests approaching 50,000 annually for emergency drug release program.
    Robinson A
    CMAJ; 1995 Sep; 153(5):665-6. PubMed ID: 7641166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Emergency Drug Release Program: regulatory aspects of new drug access in Canada.
    Gilron I
    CMAJ; 1993 Apr; 148(7):1151-3. PubMed ID: 8457955
    [No Abstract]   [Full Text] [Related]  

  • 3. Health Canada's Progressive Licensing Framework.
    Yeates N; Lee DK; Maher M
    CMAJ; 2007 Jun; 176(13):1845-7. PubMed ID: 17576983
    [No Abstract]   [Full Text] [Related]  

  • 4. Formulating an effective response to emergency room drug diversion by drug seeking patients.
    Clark S
    J Healthc Prot Manage; 2009; 25(1):1-8. PubMed ID: 19323241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians among many participants in midst of Canada's emotional gun-control debate.
    LeBourdais E
    CMAJ; 1995 Jun; 152(12):2024-7. PubMed ID: 7780910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Canada's use of its priority review process for new drugs: a cohort study.
    Lexchin J
    BMJ Open; 2015 May; 5(5):e006816. PubMed ID: 25967989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicines to remain with European Commission health directorate.
    Watson R
    BMJ; 2014 Oct; 349():g6514. PubMed ID: 25355097
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of wet nebulized inhaled respiratory medications under criteria-based reimbursement guidelines in a publicly funded Seniors' Pharmacare Program in Nova Scotia, Canada.
    Bowles SK; Sketris I; Kephart G;
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):120-8. PubMed ID: 17719514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
    Openshaw MS
    Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal products begin to attract the attention of brand-name drug companies.
    Cottrell K
    CMAJ; 1996 Jul; 155(2):216-9. PubMed ID: 8800080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closing Remarks.
    Reed E
    Oncologist; 1996; 1(4):276-277. PubMed ID: 10388002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The perverted irony of Health Canada's Special Access Programme.
    Christie TK; Montaner JS
    CMAJ; 2006 Jun; 174(12):1746. PubMed ID: 16754908
    [No Abstract]   [Full Text] [Related]  

  • 14. Health Canada targets postmarket surveillance of drugs.
    Sibbald B
    CMAJ; 2002 Jun; 166(12):1580. PubMed ID: 12074132
    [No Abstract]   [Full Text] [Related]  

  • 15. Canada's health plan not socialized medicine, says head of program.
    Armstrong RA
    Rev Fed Am Hosp; 1978 Aug; 11(5):22-4. PubMed ID: 10308082
    [No Abstract]   [Full Text] [Related]  

  • 16. [EURO-Medicines: a European program for bringing into agreement public health policies on drugs].
    Calamo-Specchia F; Bucci R; Folino-Gallo P
    Ann Ig; 1998; 10(5-6):405-12. PubMed ID: 10052204
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of essential drugs. Seventh report of the WHO Expert Committee.
    World Health Organ Tech Rep Ser; 1997; 867():1-74. PubMed ID: 9299932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptance of HIV in Cote d'Ivoire earns praise.
    AIDS Wkly Plus; 1996 Apr; ():15-6. PubMed ID: 12290906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nevirapine receives green light from Health Protection Branch.
    TreatmentUpdate; 1998 Oct; 10(8):4-5. PubMed ID: 11365878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A national drug agency.
    West R; Borden EK; Collet JP; Rawson NS; Tonks RS
    CMAJ; 2003 Apr; 168(8):962-3. PubMed ID: 12695372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.